BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6620483)

  • 1. Familial aggregation of lipids and lipoproteins and early identification of dyslipoproteinemia. The Collaborative Lipid Research Clinics Family Study.
    Morrison JA; Namboodiri K; Green P; Martin J; Glueck CJ
    JAMA; 1983 Oct; 250(14):1860-8. PubMed ID: 6620483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial associations of lipids and lipoproteins in families of hypercholesterolemic probands.
    Morrison JA; Khoury P; Laskarzewski PM; Mellies MJ; Heinemeyer R; Glueck CJ
    Arteriosclerosis; 1982; 2(2):151-9. PubMed ID: 7065982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 4. Progeny's lipid and lipoprotein levels by parental mortality. The Lipid Research Clinics Program Prevalence Study.
    Glueck CJ; Laskarzewski PM; Suchindran CM; Chambless LE; Barrett-Connor E; Stewart P; Heiss G; Tyroler HA
    Circulation; 1986 Jan; 73(1 Pt 2):I51-61. PubMed ID: 3940684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary and familial hypoalphalipoproteinemia.
    Third JL; Montag J; Flynn M; Freidel J; Laskarzewski P; Glueck CJ
    Metabolism; 1984 Feb; 33(2):136-46. PubMed ID: 6694557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study from Navarra. Hyperlipidemias. Avarage scores and percentiles for lipids and lipoproteins in a population of children and adolescents. Correlation with anthropometric parameters].
    Elcarte López R; Villa-Elizaga I; Sada Goñi J; Gasco Eguiluz M; Oyarzábal Irigoyen M; Sola Mateos A; García Ibero C; Elcarte López T; Ferrer Giménez M; Fontaneda Estíbaliz A
    An Esp Pediatr; 1993 Apr; 38(4):307-15. PubMed ID: 8480942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in serum lipid levels, lipid composition and lipoprotein fractions in patients with ischemic cardiopathies or arterial hypertension].
    Dakovska L; Orbetzov M; Orbetzova V; Yarovska N
    Paroi Arterielle; 1981; 7(1):15-22. PubMed ID: 7339537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L; Karádi I; Simonyi E
    Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid chemical parameters and incidence of genetically determined hyperlipoproteinemias in patients between 20 and 45 years of age with coronary heart disease].
    Wichmann T; Freye HA; Meyer E; Teichmann W; Schmerling S
    Z Gesamte Inn Med; 1982 Jun; 37(12):379-83. PubMed ID: 7124037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between dyslipoproteinemia and coronary risk. Therapeutic effect of essential phospholipids on LDL/HDL].
    Diamantopoulos EJ; Varsou L
    Med Welt; 1979; 30(48):1827-32. PubMed ID: 230406
    [No Abstract]   [Full Text] [Related]  

  • 11. Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia.
    Teng B; Thompson GR; Sniderman AD; Forte TM; Krauss RM; Kwiterovich PO
    Proc Natl Acad Sci U S A; 1983 Nov; 80(21):6662-6. PubMed ID: 6579550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.
    Rössner S
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S201-5. PubMed ID: 6177957
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of familial hyper- and hypolipoproteinemias: the Princeton School District Family Study.
    Laskarzewski PM; Khoury P; Morrison JA; Kelly K; Mellies MJ; Glueck CJ
    Metabolism; 1982 Jun; 31(6):558-77. PubMed ID: 7078433
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical aspects of the problem of hyperlipoproteinemia and age].
    Reuter W
    Z Gesamte Inn Med; 1981 Mar; 36(5):141-5. PubMed ID: 7018098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperbetalipoproteinaemia and hyperalphalipoproteinaemia in a single family.
    Nye ER; Harding DR; Hancock WS; Janus ED
    N Z Med J; 1983 Feb; 96(725):85-8. PubMed ID: 6571965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrafamilial associations of lipids and lipoproteins in kindreds with hypertriglyceridemic probands: the Princeton School family Study.
    Morrison JA; Khoury P; Laskarzewski PM; Mellies MJ; Kelly K; Glueck CJ
    Circulation; 1982 Jul; 66(1):67-76. PubMed ID: 7083523
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of lipid disorders to coronary heart disease.
    Glueck CJ
    Am J Med; 1983 May; 74(5A):10-4. PubMed ID: 6846376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apolipoproteins - an important diagnostic indicator in the evaluation of coronary disease risk].
    Naruszewicz M; Nowicka G
    Pol Arch Med Wewn; 1980 Aug; 64(2):161-6. PubMed ID: 7433154
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and management of familial dyslipoproteinemia in children and adolescents.
    Kwiterovich PO
    Pediatr Clin North Am; 1990 Dec; 37(6):1489-523. PubMed ID: 2259550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Columbia Population Study. II. Familial aggregation of plasma cholesterol and triglycerides.
    Chase GA; Kwiterovich PO; Bachorik PS
    Johns Hopkins Med J; 1979 Oct; 145(4):150-6. PubMed ID: 491335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.